Hassel, J. C., Piperno-Neumann, S., Rutkowski, P., Baurain, J., Schlaak, M., Butler, M. O., . . . Nathan, P. (2023). Three-year overall survival with tebentafusp in metastatic uveal melanoma. The New England journal of medicine, 389(24), . https://doi.org/10.1056/NEJMoa2304753
Chicago-Zitierstil (17. Ausg.)Hassel, Jessica C., et al. "Three-year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma." The New England Journal of Medicine 389, no. 24 (2023). https://doi.org/10.1056/NEJMoa2304753.
MLA-Zitierstil (9. Ausg.)Hassel, Jessica C., et al. "Three-year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma." The New England Journal of Medicine, vol. 389, no. 24, 2023, https://doi.org/10.1056/NEJMoa2304753.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.